Speech therapy in the treatment of Parkinson’s disease

Parkinson's Disease, Second Edition

Volumn , Issue , 2012, Pages 945-957

  Sapir, Shimon ^a   Ramig, Lorraine ^b   Fox, Cynthia ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901031489     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12948     Document Type: Chapter

References (179)

1. Ackermann, H., Konczak, J., and Hertrich, I. 1997. The temporal control of repetitive articulatory movements in Parkinson’s disease. Brain Lang 56: 312-319.
2. Ackermann, H., Wildgruber, D., Daum, I., and Grodd, W. 1998. Does the cerebellum contribute to cognitive aspects of speech production? A functional magnetic resonance imaging (fMRI) study in humans. Neurosci Lett 247: 187-190.
3. Ackermann, H. and Ziegler, W. 1991. Articulatory deficits in parkinsonian dysarthria: An acoustic analysis. J Neurol Neurosurg Psychiatry 54: 1093-1098.
4. Adams, S.G. 1997. Hypokinetic dysarthria in Parkinson’s disease. In Clinical Management of Sensorimotor Speech Disorders, ed. M.R. McNeil. New York: Thieme.
5. Ahlskog, J.E. 2007. Beating a dead horse: dopamine and Parkinson disease. Neurology 69: 1701-1711.
6. Albin, R.L., Young, A.B., and Penny, J.B. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366-375.
7. Allan, C.M. 1970. Treatment of non-fluent speech resulting from neurological disease: Treatment of dysarthria. Br J Disord Comm 5: 3-5.
8. Allen, G. 1973. Segmental timing control in speech production. J Phon 1: 219-237.
9. Aronson, A.E. 1990. Clinical Voice Disorders. New York: Thieme-Stratton.
10. Artieda, J., Pastor, M.A., Lacruz, F., and Obeso, J.A. 1992. Temporal discrimination is abnormal in Parkinson’s disease. Brain 115: 199-210.
11. Astrand, P.O. and Rodahl, K. 1970. Textbook of Work Physiology. New York: McGraw-Hill.
12. Atarashi, J. and Uchida, E. 1959. A clinical study of parkinsonism. Rec Adv Res Nerv Syst 3: 871-882.
13. Baker, K., Ramig, L.O., Johnson, A., et al. 1997. Preliminary speech and voice analysis following fetal dopamine transplants in 5 individuals with Parkinson disease. J Speech Hear Res 40: 615-626.
14. Bartels, A.L. and Leenders, K.L. 2009. Parkinson’s disease: The syndrome, the pathogenesis and pathophysiology. Cortex 45: 915-21.
15. Baumgartner, C.A., Sapir, S., and Ramig, L.O. 2001. Voice quality changes following phonatory-respiratory effort treatment (LSVT®) versus respiratory effort treatment for individuals with Parkinson disease. J Voice 15: 105-14.
16. Berardelli, A., Dick, J.P., Rothwell, J.C., Day, B.L., and Marsden, C.D. 1986. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 49: 1273-1279.
17. Bohnen, N.I., Kaufer, D.I., Hendrickson, R., et al. 2006. Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia. J Neurol 253: 242-247.
18. Borod, J.C., Koff, E., Lorch, M.P., and Nicholas, M. 1985. Channels of emotional expression in patients with unilateral brain damage. Arch Neurol 42: 345-348.
19. Borod, J.C., Pick, L.H., Hall, S., et al. 2000. Relationships among facial, prosodic, and lexical channels of emotional perceptual processing. Cognition Emotion 14: 193-211.
20. Borod, J.C., Welkowitz, J., Alpert, M., et al. 1990. Parameters of emotional processing in neuropsychiatric disorders: Conceptual issues and a battery of tests. J Commun Disord 23(4-5): 247-271.
21. Caligiuri, M. 1989. The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria. Brain Lang 36: 493-502.
22. Caligiuri, M. and Abbs, J.H. 1987. Response properties of the perioral reflex in Parkinson’s disease. Exp Neurol 98: 563-572.
23. Canino, E., Borod, J.C., Madigan, N., Tabert, M.H., and Schmidt, J.M. 1999. Development of procedures for rating posed emotional expressions across facial, prosodic, and lexical channels. Percept Mot Skills 89(1): 57-71.
24. Countryman, S., Hicks, J., and Ramig, L. 1997. Supraglottic hyperadduction in an individual with Parkinson disease: Treatment outcome. Am J Speech Lang Path 6(2): 85-94.
25. Cramer, W. 1940. De spaak bij patienten met Parkinsonisme. Logop Phoniatr 22: 17-23.
26. Critchley, E.M.R. 1981. Speech disorders of parkinsonism: A review. J Neurol Neurosurg Psychiatry 44: 751-758.
27. Cunnington, R., Iansek, R., and Bradshaw, J.L. 1999. Movement-related potentials in Parkinson’s disease: External cues and attentional strategies. Mov Disord 14: 63-68.
28. D’Amelio, M., Ragonese, P., Morgante, L., et al. 2006. Long-term survival of Parkinson’s disease: A population-based study. J Neurol 253: 33-37.
29. Darley, F.L., Aronson, A.E., and Brown, J.R. 1969a. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 12: 462-469.
30. Darley, F.L., Aronson, A., and Brown, J. 1969b. Differential diagnostic patterns of dysarthria. J Speech Hear Res 12: 246-269.
31. Demirci, M., Grill, S., McShane, L., and Hallet, M. 1995. Impairment of kinesthesia in Parkinson’s disease. Neurology 45: A218.
32. Demirci, M., Grill, S., McShane, L., and Hallett, M. 1997. A mismatch between kinesthetic and visual perception in Parkinson’s disease. Ann Neurol 41: 781-788.
33. Desmurget, M., Grafton, S.T., Vindras, P., Gréa, H., and Turner, R.S. 2003. Basal ganglia network mediates the control of movement amplitude. Exp Brain Res 153: 197-209.
34. Desmurget, M., Grafton, S.T., Vindras, P., Gréa, H., and Turner, R.S. 2004. The basal ganglia network mediates the planning of movement amplitude. Eur J Neurosci 19: 2871-2880.
35. Diamond, S.G., Schneider, J.S., and Markham, C.H. 1987. Oral sensorimotor defects in people with Parkinson’s disease. Adv Neurol 45: 335-338.
36. Dowding, C.H., Shenton, C.L., and Salek, S.S. 2006. A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs Aging 23: 693-721.
37. Downie, A.W., Low, J.M., and Lindsay, D.D. 1981. Speech disorders in parkinsonism: Usefulness of delayed auditory feedback in selected cases. Br J Disord Comm 16: 135-139.
38. Dromey, C. and Ramig, L. 1998. Intentional changes in sound pressure level and rate: Their impact on measures of respiration, phonation, and articulation. J Speech Lang Hear Res 41: 1003-1018.
39. Dromey, C., Ramig, L.O., and Johnson, A. 1995. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: A case study. J Speech Hear Res 38: 751-763.
40. Findley, L.J. 2007. The economic impact of Parkinson’s disease. Parkinsonism Relat Disord 13 (Suppl): S8-S12.
41. Fisher, B., Petzinger, G., Nixon, K., et al. 2004. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 77: 378-390.
42. Forrest, K., Weismer, G., and Turner, G.S. 1989. Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. J Acoust Soc Am 85: 2608-2622.
43. Fox, C. and Ramig, L. 1997. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Pathol 2: 29-42.
44. Fox, C., Ramig, L., Ciucci, M., et al. 2006. The Science and Practice of LSVT/LOUD: Neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin Speech Lang 27(4): 283-299.
45. Gandour, J., Dechongkit, S., Ponglorpisit, S., and Khunadorn, F. 1994. Speech timing at the sentence level in Thai after unilateral brain damage. Brain Lang 46: 419-438.
46. Gentil, M., Chauvin, P., Pinto, S., Pollak, P., and Benabid, A.L. 2001. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang 78: 233-240.
47. Gentil, M., Garcia-Ruiz, P., Pollak, P., and Benabid, A.L. 2000. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism. Eur Neurol 44: 147-152.
48. Gentil, M., Pinto, S., Pollak, P., and Benabid, A.L. 2003. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain Lang 85: 190-196.
49. Goberman, A. 2005. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson disease. Med Sci Monit 11: CR109-CR116.
50. Goberman, A., Coelho, C., and Robb, M. 2002. Phonatory characteristics of parkinsonian speech before and after morning medication: The ON and OFF states. J Communic Disord 35: 217-239.
51. Goberman, A.M. and Elmer, L.W. 2005. Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. J Communicat Disord 38: 215-230.
52. Graber, S., Hertrich, I., Daum, I., Spieker, S., and Ackermann, H. 2002. Speech perception deficits in Parkinson’s disease: Underestimation of time intervals compromises identification of durational phonetic contrasts. Brain Lang 82: 65-74.
53. Greene, H.C.L. 1980. The Voice and Its Disorders. London: Pitman Medical.
54. Hallet, M. 1997. Sensorimotor integration and mysterious sensory phenomena in movement disorders. In Motor Control, ed. M. Hallet. St. Paul, MN: American Academy of Neurology.
55. Halpern, A.E., Matos, C., Ramig, L.O., Petska, J., and Spielman, J. 2004. LSVTC-A PDA supported speech treatment for Parkinson’s disease. Presented at Annual American Speech-Language-Hearing Association Meeting. Philadelphia, PA.
56. Halpern, A., Matos, C., Ramig, L., et al. 2005. LSVTC- A PDA supported speech treatment for Parkinson’s disease. Presented at 9th International Congress of Parkinson’s Disease and Movement Disorders. New Orleans, LA.
57. Hammen, V.L., and Yorkston, K.M. 1996. Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria. J Commun Disord 29: 429-444.
58. Hammen, V.L., Yorkston, K.M., and Minifie, F.D. 1994. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria. J Speech Hear Res 37: 244-253.
59. Hartelius, L. and Svensson, P. 1994. Speech and swallowing symptoms associated with Parkinson’s disease and multiple sclerosis: A survey. Folia Phoniat Logoped 46: 9-17.
60. Helm, N. 1979. Management of palilalia with a pacing board. J Speech Hear Disord 44: 350-353.
61. Higgins, M.B., Netsell, R., and Schulte, L. 1998. Vowel-related differences in laryngeal articulatory and phonatory function. J Speech Lang Hear Res 41: 712-724.
62. Hirano, S., Kojima, H., Naito Y., et al. 1996. Cortical speech processing mechanisms while vocalizing visually presented languages. NeuroReport 8: 363-367.
63. Ho, A.K., Bradshaw, J.L., and Iansek, T. 2000. Volume perception in parkinsonian speech. Mov Disord 15: 1125-1131.
64. Ho, A.K., Bradshaw, J.L., Iansek, R., and Alfredson. R. 1999a. Speech volume regulation in Parkinson’s disease: Effects of implicit cues and explicit instructions. Neuropsychologia 37: 1453-1460.
65. Ho, A.K., Iansek, R., and Bradshaw, J.L. 1999b. Regulations of parkinsonian speech volume: The effect of interlocuter distance. J Neurol Neurosurg Psychiatry 67(2): 199-202.
66. Ho, A.K., Iansek, R., and Bradshaw, J.L. 2001. Motor instability in parkinsonian speech intensity. Neuropsy Neuropsy Behav Neurol 14(2): 109-116.
67. Ho, A., Iansek, R., Marigliani, C., Bradshaw, J.L., and Gates, S. 1998. Speech impairment in a large sample of people with Parkinson’s disease. Behav Neurol 11: 131-137.
68. Hocherman, S., Moont, R., and Schwartz, M. 2004. Recruitment of attentional resources during visuomotor tracking: Effects of Parkinson’s disease and age. Brain Res Cogn Brain Res 21: 77-86.
69. Huber, J., Stathopoulos, E., Ramig, L., and Lancaster, S. 2003. Respiratory function and variability in individuals with Parkinson disease: Pre and post Lee Silverman Voice Treatment (LSVT®). J Med Speech Lang Pathol 11(4): 185-201.
70. Hunter, P.C., Crameri, J., Austin, S., Woodward, M.C., and Hughes, A.J. 1997. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry 63: 579-583.
71. Jobst, E.E., Melnick, M.E., Byl, N.N., Dowling, G.A., and Aminoff, M.J. 1997. Sensory perception in Parkinson’s disease. Arch Neurol 54: 450-454.
72. Jones, H. N., Kendall, D.L., Sudhyadhom, A., and Rosenbek, J.C. 2007. The effects of lesion therapy and deep brain stimulation on speech function in patients with Parkinson disease. Comm Disord Rev 1(3-4): 133-173.
73. Jones, C.R., Malone, T.J., Dirnberger, G., Edwards, M., and Jahanshahi, M. 2008. Basal ganglia, dopamine and temporal processing: Performance on three timing tasks on and off medication in Parkinson’s disease. Brain Cogn 68: 30-41.
74. Jurgens, U., Kirzinger, A., and von Cramon, D. 1982. The effects of deep-reaching lesions in the cortical face area on phonation. A combined case report and experimental monkey study. Cortex 18: 125-130.
75. Kempler, D. and Van Lancker, D. 2002. Effect of speech task on intelligibility in dysarthria: A case study of Parkinson’s disease. Brain Lang 80: 449-464.
76. King, J., Ramig, L., Lemke, J.H., and Horii, Y. 1994. Parkinson disease: Longitudinal changes in acoustic parameters of phonation. J Med Speech Lang Pathol 2: 29-42.
77. Kitchen, D.M., Cheney, D.L., and Seyfarth, R.M. 2005. Male chacma baboons (Papio hamadryas ursinus) discriminate loud call contests between rivals of different relative ranks. Anim Cogn 8: 1-6.
78. Kleim, J., Jones, T., and Schallert, T. 2003. Motor enrichment and the induction of plasticity before or after brain injury, Neurochem Res 11: 1757-1769.
79. Kleinow, J., Smith, A., and Ramig, L. 2001. Speech stability in idiopathic Parkinson disease: Effects of rate and loudness manipulations. J Speech Lang Hear Res 44(5): 1041-1051.
80. Klockgether, T., Borutta, M., Rapp, H., Spieder, S., and Dichgans, J. 1997. A defect of kinesthesia in Parkinson’s disease. Brain 120: 460-465.
81. Knudsen, E.I. 2007. Fundamental components of attention. Annu Rev Neurosci 30: 57-78.
82. Kompoliti, K., Wang, Q.E., Goetz, C.G., Leurgans, S., and Raman, R. 2000. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s disease. Neurology 54: 458-462.
83. Konczak, J., Ackermann, H., Hertrich, I., Spieker, S., and Dichgans, J. 1997. Control of repetitive lip and finger movements in Parkinson’s disease: Influence of external timing signals and simultaneous execution on motor performance. Mov Disord 12: 665-676.
84. Larson, K.K. and Sapir, S. 1995. Orolaryngeal reflex responses to changes in affective state. J Speech Lang Hear Res 38: 990-1000.
85. Leinonen, L., Laakso, M.L., Carlson, S., and Linnankoski, I. 2003. Shared means and meanings in vocal expression of man and macaque. Logoped Phoniatr Vocol 28: 53-61.
86. Liepert, J., Miltner, W., Bauder, H., et al. 1998. Motor cortex plasticity during constraint-induced movement therapy in stroke patients. Neurosci Lett 250: 5-8.
87. Liotti, M., Ramig, L.O., Vogel, D., et al. 2003. Hypophonia in Parkinson’s disease: Neural correlates of voice treatment revealed by PET. Neurology 60: 432-440.
88. Liotti, M., Vogel, D., Sapir, S., et al. 2000. Abnormal auditory gating in Parkinson’s disease before & after LSVT®. Paper presented at the Annual Meeting of the American Speech, Language and Hearing Association, Washington, DC.
89. Liss, J.M., Spitzer, S.M., Caviness, J.N., and Adler, C. 2002. The effects of familiarization on intelligibility and lexical segmentation in hypokinetic and ataxic dysarthria. J Acoust Soc Am 112(6): 3022-3030.
90. Logemann, J., Boshes, B., and Fisher, H. 1973. The steps in the degeneration of speech and voice control in Parkinson’s disease. In Parkinson’s Diseases: Rigidity, Akinesia, Behavior, ed. J. Siegfried. Vienna: Hans Huber.
91. Logemann, J., Fisher, H., Boshes, B., and Blonsky, E. 1978. Frequency and concurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 43: 47-57.
92. Ludlow, C.L. and Bassich, C.J. 1984. Relationships between perceptual ratings and acoustic measures of hypokinetic speech. In The Dysarthrias: Physiology, Acoustics, Perception, Management, eds. M.R. McNeil, J.C. Rosenbek, and A.E. Aronson. San Diego, CA: College-Hill Press.
93. Ludlow, C.L., Connor, N.P., and Bassich, C.J. 1987. Speech timing in Parkinson’s and Huntington’s disease. Brain Lang 32: 195-214.
94. Luschei, E.S., Ramig, L.O., Baker, K.L., Baker, K.L., and Smith, M.E. 1999. Discharge characteristics of laryngeal single motor units during phonation in young and older adults and in persons with Parkinson disease. J Neurophys 81: 2131-2139.
95. Mawdsley, C. 1973. Speech and levodopa. Adv Neurology 3: 33-47.
96. Mawdsley, C. and Gamsu, C.V. 1971. Periodicity of speech in parkinsonism. Nature 231: 315-316.
97. McClean, M.D. and Tasko, S.M. 2002. Association of orofacial with laryngeal and respiratory motor output during speech. Exp Brain Res 146: 481-489.
98. McNamara, P., Obler, L.K., Au, R., Durso, R., and Albert, M.L. 1992. Speech monitoring skills in Alzheimer’s disease, Parkinson’s disease, and normal aging. Brain Lang 42: 38-51.
99. Merchant, H., Luciana, M., Hooper, C., Majestic, S., and Tuite, P. 2008. Interval timing and Parkinson’s disease: Heterogeneity in temporal performance. Exp Brain Res 184: 233-248.
100. Miller, N., Allcock, L., Jones, D., et al. 2007. Prevalence and pattern of perceived intelligibility changes in Parkinson’s disease. J Neurol Neurosurg Psychiatry 78: 1188-1190.
101. Miller, N., Noble, E., Jones, D., Allcock, L., and Burn, D.J. 2008. How do I sound to me? Perceived changes in communication in Parkinson’s disease. Clin Rehabil 22(1): 14-22.
102. Miller, N., Noble, E., Jones, D., and Burn, D. 2006a. Hard to swallow: Dysphagia in Parkinson’s disease. Age Ageing 35: 614-618.
103. Miller, N., Noble, E., Jones, D., and Burn, D. 2006b. Life with communication changes in Parkinson’s disease. Age Ageing 35: 235-239.
104. Möbes, J., Joppich, G., Stiebritz, F., Dengler, R., and Schröder, C. 2008. Emotional speech in Parkinson’s disease. Mov Disord 23: 824-829.
105. Moreau, C., Ozsancak, C., Blatt, J.L., et al. 2007. Oral festination in Parkinson’s disease: Biomechanical analysis and correlation with festination and freezing of gait. Mov Disord 22: 1503-1506.
106. Morris, M., Iansek, R., Matyas, T., and Summers, J. 1998. Abnormalities in the stride length-cadence relation in parkinsonian gait. Mov Disord 13: 61-69.
107. Mutch, R., Strucwick, A., Roy, S., and Downie, A.W. 1986. Parkinson’s disease: Disability review and management. Br Med J 293: 675-677.
108. Nakano, K.K., Zubick, H., and Tyley, H.R. 1973. Speech defects of parkinsonian patients. Neurology 23: 865-870.
109. Narayana, S., Fox, P.T., Zhang, W., et al. 2010. Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Human Brain Mapping. 31(2): 222-236.
110. Narayana, S., Vogel, D., Brown, S., et al. 2005. Mechanism of action of voice therapy in parkinson’s hypophonia-a PET study. A poster presented at the 11th Annual Meeting of the Organization for Human Brain Mapping. Toronto, Ontario, Canada.
111. Netsell, R., Daniel, B., and Celesia, G.G. 1975. Acceleration and weakness in parkinsonian dysarthria. J Speech Hear Disord 40: 170-178.
112. Ofer-Noy, N., Dudai, Y., and Karni, A. 2003. Skill learning in mirror reading: How repetition determines acquisition. Cog Brain Res 17: 507-521.
113. Oliveira, R.M., Gurd, J.M., Nixon, P., Marshall, J.C., and Passingham, R.E. 1997. Micrographia in Parkinson’s disease: The effect of providing external cues. J Neurol Neurosurg Psychiatry 63(4): 429-433.
114. Pell, M.D., Cheang, H.S., and Leonard, C.L. 2006. The impact of Parkinson’s disease on vocal-prosodic communication from the perspective of listeners. Brain Lang 97: 123-134.
115. Penny, J.B. and Young, A.B. 1983. Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neuroscience 6: 73-94.
116. Perez, K., Ramig, L.O., Smith, M., and Dromey, C. 1996. The parkinson larynx: Tremor and videostroboscopic findings. J Voice 10: 354-361.
117. Pinto, S., Gentil, M., Fraix, V., Benabid, A.L., and Pollak, P. 2003. Bilateral subthalamic stimulation effects on oral force control in Parkinson’s disease. J Neurology 250: 179-187.
118. Pinto, S., Ozsancak, C., Tripoliti, E., et al. 2004. Treatments for dysarthria in Parkinson’s disease. Lancet Neurol 3: 547-556.
119. Pitcairn, T.K., Clemie, S., Gray, J.M., and Pentland, B. 1990. Non-verbal cues in the self-presentation of parkinsonian patients. Br J Clin Psychol 29: 177-184.
120. Plowman-Prine, E.K., Okun, M.S., Sapienza, C.M., et al. 2009. Perceptual characteristics of Parkinsonian speech: A comparison of the pharmacological effects of levodopa across speech and non-speech motor systems. NeuroRehabilitation 24: 131-144.
121. Porges, S.W. 1995. Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A polyvagal theory. Psychophysiology 32(4): 301-318.
122. Porges, S.W. 1997. Emotion: An evolutionary by-product of the neural regulation of the autonomic nervous system. Ann N Y Acad Sci 807: 62-77.
123. Radad, K., Gille, G., and Rausch, W. 2005. Short review on dopamine agonists: Insight into clinical and research studies relevant to Parkinson’s disease. Pharmacol Rep 57: 701-712.
124. Rajput, A., and Rajput, A.H. 2006. Parkinson’s disease management strategies. Expert Rev Neurother 6: 91-99.
125. Ramig, L. 1992. The role of phonation in speech intelligibility: A review and preliminary data from patients with Parkinson’s disease. In Intelligibility in Speech Disorders: Theory, Measurement, and Management, ed. R.D. Kent, 119-156. Amsterdam: John Benjamin.
126. Ramig, L.O. and Dromey, C. 1996. Aerodynamic mechanisms underlying treatment-related changes in SPL in patients with Parkinson disease. J Speech Hear Res 39: 798-807.
127. Ramig, L., Fox, C., and Sapir, S. 2008. Speech treatment for Parkinson disease. Expert Rev Neurotherapeutics 8: 299-311.
128. Ramig, L., Mead, C., Scherer, R., et al. 1988a. Voice therapy and Parkinson’s disease: A longitudinal study of efficacy. Paper presented at the Clinical Dysarthria Conference, San Diego, CA, February.
129. Ramig, L.O., Pawlas, A., and Countryman, S. 1995. The Lee Silver man Voice Treatment (LSVT®): A practical guide to treating the voice and speech disorders in Parkinson disease. National Center for Voice and Speech and LSVT® Foundation (1-888-606-5788), Iowa City, IA.
130. Ramig, L.O., Sapir, S., Countryman, S., et al. 2001. Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: A 2 year follow up. J Neurol Neurosurg Psychiatry 71: 493-498.
131. Ramig, L., Scherer, R., Titze, I., and Ringel, S. 1988b. Acoustic characteristics of voice of patients with neurological disease: A preliminary report. Ann Otol Rhinol Laryngol 97(2): 164-172.
132. Rektorova, I., Barrett, J., Mikl, M., Rektor, I., and Paus, T. 2007. Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson’s disease. Mov Disord 22: 2043-2051.
133. Rickards, C. and Cody, F.W. 1997. Proprioceptive control of wrist movements in Parkinson’s disease. Brain 120: 977-990.
134. Rigrodsky, S. and Morrison, E.B. 1970. Speech changes in parkinsonism during l-dopa therapy: Preliminary findings. J Am Geriatr Soc 18: 142-151.
135. Rosen, K.M., Kent, R.D., and Duffy, J.R. 2005. Task-based profile of vocal intensity decline in Parkinson’s disease. Folia Phoniatr Logoped 57: 28-37.
136. Ross, E.D. and Mesulam, M.M. 1979. Dominant language functions of the right hemisphere? Prosody and emotional gesturing. Arch Neurol 36(3): 144-148.
137. Rowe, J., Stephan, K.E., Friston, K., et al. 2002. Attention to action in Parkinson’s disease: Impaired effective connectivity among frontal cortical regions. Brain 125(Pt 2): 276-278.
138. Sapir, S. 1989. The intrinsic pitch of vowels: Theoretical, physiological, and clinical considerations. J Voice 3: 44-51.
139. Sapir, S., Pawlas, A.A., Ramig, L.O., et al. 2001. Voice and speech abnormalities in Parkinson disease: Relation to severity of motor impairment, duration of disease, medication, depression, gender, and age. J Med Speech Lang Path 9: 213-226.
140. Sapir, S., Ramig, L., and Fox, C. 2006. The Lee Silverman voice treatment for voice, speech and other orofacial disorders in patients with Parkinson’s disease. Future Neurol 1: 563-570.
141. Sapir, S., Ramig, L., and Fox, C. 2008a. Voice, speech and swallowing disorders. In Parkinson Disease: Diagnosis and Clinical Management, eds. S. Factor and W. Weiner, 77-97. New York City: Demos Medical Publishing.
142. Sapir, S., Ramig, L., and Fox, C. 2008b. Speech and swallowing disorders in Parkinson’s disease. Curr Opin Otolaryngol Head Neck Surg 16: 205-210.
143. Sapir, S., Ramig, L., Hoyt, P., O’Brien, C., and Hoehn, M. 2002. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson’s disease: A comparison with an alternative speech treatment. Folia Phoniatrica 54: 296-303.
144. Sapir, S., Ramig, L.O., Spielman, J.L., and Fox, C. 2010. Formant centralization ratio (FCR): A proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res. 53(1): 114-125.
145. Sapir, S., Spielman, J., Ramig, L., Story, B., and Fox, C. 2007. Effects of intensive voice treatment (LSVT®) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual findings. J Speech Lang Hear Res 50: 889-912.
146. Sarno, M.T. 1968. Speech impairment in Parkinson’s disease. Arch Phys Med Rehabil 49(5): 269-275.
147. Schenkman, M., Zhu, C.W., Cutson, T.M., and Whetten-Goldstein, K. 2001. Longitudinal evaluation of economic and physical impact of Parkinson’s disease. Parkinsonism Relat Disord 2: 41-50.
148. Schmidt, R.A. 1975. A schema theory of discrete motor skill learning. Psychol Rev 82: 225-260.
149. Schmidt, R.A. 1988. Motor Control and Learning. Champaign, IL: Human Kinetic.
150. Schneider, J.S., Diamond, S.G., and Markham, C.H. 1986. Deficits in orofacial sensorimotor function in Parkinson’s disease. Ann Neurol 19: 275-282.
151. Schneider, J.S. and Lidsky, T.I. 1987. Basal Ganglia and Behavior: Sensory Aspects of Motor Functioning. Toronto, Canada: Hans Huber.
152. Schulz, G.M. 2002. The effects of speech therapy and pharmacological treatments on voice and speech in Parkinsons disease: A review of the literature. Curr Med Chem 9: 1359-1366.
153. Sharkawi, A.E., Ramig, L., Logemann, J.A., et al. 2002. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): A pilot study. J Neurol Neurosurg Psychiatry 72: 31-36.
154. Skodda, S., Rinsche, H., and Schlegel, U. 2009. Progression of dysprosody in Parkinson’s disease over time-a longitudinal study. Mov Disord 24: 716-722.
155. Skodda, S. and Schlegel, U. 2008. Speech rate and rhythm in Parkinson’s disease. Mov Disord 23(7): 985-992.
156. Smith, M., Ramig, L.O., Dromey, C., Perez, K., and Samandari, R. 1995. Intensive voice treatment in Parkinson’s disease: Laryngostroboscopic findings. J Voice 9: 453-459.
157. Solomon, N.P. and Hixon, T.J. 1993. Speech breathing in Parkinson’s disease. J Speech Lang Hear Res 36: 294-310.
158. Solomon, N.P., Robin, D.A., Lorell, D.M., Rodnitzky, R.L., and Luschei, E.S. 1994. Tongue function testing in Parkinson’s disease: indicators of fatigue. In Motor Speech Disorders: Advances in Assessment and Treatment, eds. J.A. Till, K.M. Yorkston, and R. Beukelman, pp. 147-160. Baltimore, MD: Paul H. Brooks.
159. Spencer, K., Morgan, K., and Blond, E. 2009. Dopaminegic medication effects on the speech of individuals with Parkinson’s disease. J Med Speech Lang Pathol 17: 125-144.
160. Spielman, J., Borod, J., and Ramig, L. 2003. The effects of intensive voice treatment on facial expressiveness in Parkinson disease: Preliminary data. Cogn Behav Neurol 16: 177-188.
161. Stelmach, G.E. 1991. Basal ganglia impairment and force control. In Tutorial in Motor Neuroscience, eds. J. Requin and G.E. Stelmach. Netherlands: Kluwer Academic Publishers.
162. Stewart, C., Winfield, L., Hunt, A., et al. 1995. Speech dysfunction in early Parkinson’s disease. Mov Disord 10(5): 562-565.
163. Taub, E. 2004. Harnessing brain plasticity through behavioral techniques to produce new treatments in neurorehabilitation. Am Psychol 59(8): 692-704.
164. Theodoros, D.G., Constantinescu, G., Russell, T.G., et al. 2006. Treating the speech disorder in Parkinson’s disease online. J Telemed Telecare 12(Suppl 3): 88-91.
165. Tillerson, J., Caudle, W.M., Reveron, M.E., and Miller, G.W. 2003. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson’s disease. Neuroscience 119: 899-911.
166. Tillerson, J. and Miller, G. 2002. Forced limb-use and recovery following brain injury. Neuroscientist 8: 574-585.
167. Tison, F., Wiart, L., Guatterie, M., et al. 1996. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease. Mov Disord 11: 729-732.
168. Tjaden, K. and Wilding, G.E. 2004. Rate and loudness manipulations in dysarthria: Acoustic and perceptual findings. Speech Lang Hear Res 47: 766-783.
169. Trail, M., Fox, C., Ramig, L.O., et al. 2005. Speech treatment for Parkinson’s disease. NeuroRehabilitation 20: 205-221.
170. Volkmann, J., Hefter, H., Lange, H.W., and Freund, H.J. 1992. Impairment of temporal organization of speech in basal ganglia diseases. Brain Lang 43: 386-399.
171. Weiner, W.J. and Lang, A.E. 1989. Movement Disorders: A Comprehensive Survey. Mount Kisco, NY: Futura.
172. Wermuth, L., Stenager, E.N., Stenager, E., and Boldsen, J. 1995. Mortality in patients with Parkinson’s disease. Acta Neurol Scand 92: 55-58.
173. Winholtz, W. and Ramig, L. 1992. The vocal demodulator for analysis of vocal tremor. J Speech Hear Res 35: 562-573.
174. Wolfe, V.I., Garvin, J., Bacon, M., and Waldrop, W. 1975. Speech changes in Parkinson’s disease during treatment with l-dopa. J Communic Disord 8(3): 271-279.
175. Wu, T. and Hallett, M. 2008. Neural correlates of dual task performance in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 79: 760-766.
176. Yaryura-Tobias, J.A., Diamond, B., and Merlis, S. 1971. Verbal communication with l-dopa treatment. Nature 234: 224-225.
177. Yorkston, K.M. 1996. Treatment efficacy: Dysarthria. J Speech Hear Res 39: S46- S57.
178. Yorkston, K.M., Hakel, M., Beukelman, D.R., and Fager, S. 2007. Evidence for effectiveness of treatment of loudness, rate, or prosody in dysarthria: A systematic review. J Med Speech Lang Pathol 15(2): 11-36.
179. Yorkston, K.M., Spencer, K.A., and Duffy, J.R. 2003. Behavioral management of respiratory/phonatory dysfunction from dysarthria: A systematic review of the evidence. J Med Speech Lang Pathol 11: 13-38.